Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion (Q40586631)

21 September 2017

title

Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion (English)

1 reference

21 September 2017

Anne U Holland

1

1 reference

21 September 2017

Carsten Munk

2

1 reference

21 September 2017

Ginger R Lucero

3

1 reference

21 September 2017

Lucia D Nguyen

4

1 reference

21 September 2017

Nathaniel R Landau

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

number of pages

10

1 reference

inferred from page(s)

published in

Virology

1 reference

21 September 2017

volume

319

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

343-352

1 reference

Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

HIV-1 entry - an expanding portal for drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Epidermal growth factor receptor dimerization monitored in live cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

7 January 2021

CCR5 and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Antibodies, viruses and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

HIV entry and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Core structure of gp41 from the HIV envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

HIV-1 membrane fusion: targets of opportunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Mechanisms of viral membrane fusion and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

HIV-1 inhibition by a peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

New targets for inhibitors of HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Alpha complementation of LacZ in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Monitoring protein-protein interactions in live mammalian cells by beta-galactosidase complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Coiled coils in both intracellular vesicle and viral membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Characterization by in vitro complementation of a peptide corresponding to an operator-proximal segment of the β-galactosidase structural gene of Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

HIV receptors and cellular tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

7 January 2021

inferred from DOI database lookup

Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

7 January 2021

inferred from DOI database lookup

Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.012

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VIROL.2003.11.012

1 reference

21 September 2017

1 reference